GIACOMELLO, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 1.592
EU - Europa 407
AS - Asia 105
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.112
Nazione #
US - Stati Uniti d'America 1.586
IT - Italia 118
UA - Ucraina 103
DE - Germania 71
CN - Cina 39
FI - Finlandia 27
SE - Svezia 26
GB - Regno Unito 21
IE - Irlanda 19
IN - India 18
TR - Turchia 15
VN - Vietnam 12
IR - Iran 9
SG - Singapore 9
BE - Belgio 6
CA - Canada 6
BR - Brasile 4
FR - Francia 3
AU - Australia 2
CZ - Repubblica Ceca 2
KR - Corea 2
NL - Olanda 2
PL - Polonia 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CH - Svizzera 1
CO - Colombia 1
EU - Europa 1
HU - Ungheria 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.112
Città #
Woodbridge 214
Chandler 193
Fairfield 178
Ann Arbor 103
Houston 100
Seattle 81
Ashburn 73
Wilmington 72
Cambridge 66
Jacksonville 65
Dearborn 55
Boardman 44
Udine 25
Venezia 25
Princeton 22
Dublin 19
Izmir 15
Beijing 12
Dong Ket 12
New York 12
Redwood City 10
Singapore 9
San Diego 8
Trieste 8
Los Angeles 7
Milan 7
Redmond 7
Brussels 6
Des Moines 6
Leawood 6
Nanjing 6
Rome 6
Toronto 6
Norwalk 5
Augusta 4
Zhengzhou 4
Ardabil 3
Caserta 3
Frankfurt am Main 3
Halle 3
Hefei 3
Kunming 3
Nürnberg 3
Tavagnacco 3
Zanjan 3
Andover 2
Ansbach 2
Belgrade 2
Brno 2
Campinas 2
Codroipo 2
Grafing 2
Guangdong 2
Guarulhos 2
Helsinki 2
Monmouth Junction 2
Mumbai 2
Ogden 2
Sacramento 2
San Mateo 2
Shanghai 2
Sotto 2
Tottenham 2
Warsaw 2
Auburn Hills 1
Bologna 1
Bolzano 1
Budapest 1
Cedar Knolls 1
Central Coast 1
Chengdu 1
Dallas 1
Düsseldorf 1
Edinburgh 1
Enemonzo 1
Guangzhou 1
Hangzhou 1
Harbin 1
Jarny 1
Kish 1
Opera 1
Paris 1
Pavia 1
Phoenix 1
Preston 1
Pune 1
Sydney 1
Torino 1
Trento 1
Vienna 1
Washington 1
Yellow Springs 1
Zurich 1
Totale 1.585
Nome #
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 197
Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays. 163
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 133
Age dependency for coagulation parameters in paediatric populations: Results of a multicentre study aimed at defining the age-specific reference ranges 129
Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis 128
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 120
Variability of cut-off values for the detection of lupus anticoagulants: Results of an international multicenter multiplatform study 114
RETINAL VEIN OCCLUSION: EVALUATION OF "CLASSIC2 AND "EMERGING" RISK FACTORS AND TREATMENT 111
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 107
Functional fibrinogen (FLEV-TEG) versus the Clauss method in an obstetric population: A comparative study 100
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 98
Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress 88
Anti-vimentin/cardiolipin complex autoantibodies in antiphospholipid syndrome: preliminary data using a new ELISA method. 88
A collaborative study by the working group on hemostasis and thrombosis of the italian society of clinical biochemistry and clinical molecular biology (SIBioC) on the interference of haemolysis on five routine blood coagulation tests by evaluation of 269 paired haemolysed/non-haemolysed samples 87
Modified activated Partial thromboplastin time during liver transplantation 80
Factor V leiden increases plasma F1+2 levels both in normal and deep venous thrombosis subjects. 73
In vitro undetectable PT and Fibrinogen (and in vivo?) 71
Lupus anticoagulant: A multicenter study for a standardized and harmonized reporting 71
EFFICACIA DI UNA SINGOLA DOSE DI ENOXAPARINA SULLA COAGULAZIONE (TEG) E SUL DOSAGGIO DEL FATTORE ANTI-Xa 56
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 52
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 42
Early thromboelastography in acute traumatic coagulopathy: an observational study focusing on pre-hospital trauma care 38
Contribution and Effectiveness of Laboratory Testing in the Diagnostic Assessment of Juvenile Ischemic Stroke and Transient Ischemic Attack 11
Totale 2.157
Categoria #
all - tutte 6.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020520 0 25 23 88 44 84 60 54 45 61 6 30
2020/2021334 7 39 17 38 12 33 19 28 57 22 37 25
2021/2022230 17 30 9 11 1 7 14 4 3 34 69 31
2022/2023376 27 43 2 60 34 78 2 42 51 5 13 19
2023/2024104 19 4 2 1 8 20 0 8 6 12 1 23
2024/202534 8 26 0 0 0 0 0 0 0 0 0 0
Totale 2.157